Amarin Corporation plc (AMRN)
NASDAQ: AMRN · Real-Time Price · USD
14.25
+0.19 (1.35%)
Mar 9, 2026, 1:10 PM EDT - Market open
Amarin Corporation Employees
Amarin Corporation had 275 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
275
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$776,895
Profits / Employee
-$141,084
Market Cap
296.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| GSK plc | 68,629 |
| Bristol-Myers Squibb Company | 32,500 |
| Grifols | 23,737 |
| Organon & Co. | 10,000 |
| Biogen | 7,500 |
| Scilex Holding Company | 30 |
AMRN News
- 11 days ago - Amarin Corporation plc (AMRN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease - GlobeNewsWire
- 7 weeks ago - US Supreme Court to hear 'skinny label' patent fight involving Amarin - Reuters
- 2 months ago - Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company's VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization - GlobeNewsWire
- 4 months ago - New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients - GlobeNewsWire
- 4 months ago - Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025 - GlobeNewsWire
- 4 months ago - Amarin Corporation plc (AMRN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress - GlobeNewsWire